• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖对 SARS-CoV-2 大流行死亡率风险的影响。

The Impact of Obesity on SARS-CoV-2 Pandemic Mortality Risk.

机构信息

Center for Human Nutrition, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

Department of Allergy and Immunology, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.

出版信息

Nutrients. 2021 Sep 28;13(10):3446. doi: 10.3390/nu13103446.

DOI:10.3390/nu13103446
PMID:34684447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8538622/
Abstract

The COVID-19 pandemic has uncovered the increased susceptibility of individuals with obesity to infection and severe disease leading to hospitalization and death. Studies in New York City demonstrated that after advanced age, obesity was the most common risk factor leading to severe disease and death from COVID-19. While the connection has been recognized, there has not been a general recognition of the potential mechanisms for this link between excess body fat and mortality from this viral pandemic including respiratory complications and sequelae of increased activation of the immune system. Despite plans for vaccination of the global population, the risk community spread of COVID-19 and future pandemics will be linked in part to obesity and immunity. This review will detail a number of potential mechanisms through which obesity may contribute to the lethality of this viral infection. These insights will hopefully lead to a greater emphasis on obesity prevention and treatment as part of the global response to this and future pandemic threats.

摘要

译文:

肥胖与 COVID-19 相关死亡率之间的潜在机制

肥胖者易感染 COVID-19,且感染后易发展为重症,进而导致住院和死亡,这在疫情期间已被充分证实。纽约市的研究表明,在年龄较大的人群中,肥胖是导致 COVID-19 重症和死亡的最常见危险因素。尽管人们已经认识到肥胖与 COVID-19 相关死亡率之间存在关联,但对于这种关联的潜在机制,包括肥胖与呼吸系统并发症和免疫系统过度激活的后遗症之间的关系,尚未达成普遍共识。尽管计划对全球人口进行疫苗接种,但 COVID-19 的社区传播风险以及未来的大流行仍将部分与肥胖和免疫有关。本综述将详细介绍肥胖可能导致这种病毒感染致命性的多种潜在机制。这些见解有望促使人们更加重视肥胖的预防和治疗,将其作为应对当前和未来大流行威胁的全球应对措施的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92a/8538622/7f6350821e74/nutrients-13-03446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92a/8538622/7f6350821e74/nutrients-13-03446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b92a/8538622/7f6350821e74/nutrients-13-03446-g001.jpg

相似文献

1
The Impact of Obesity on SARS-CoV-2 Pandemic Mortality Risk.肥胖对 SARS-CoV-2 大流行死亡率风险的影响。
Nutrients. 2021 Sep 28;13(10):3446. doi: 10.3390/nu13103446.
2
Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers.在纽约市五家医疗中心,241 例严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染产妇的特征和结局。
Obstet Gynecol. 2020 Aug;136(2):273-282. doi: 10.1097/AOG.0000000000004025.
3
Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet.肥胖与新冠病毒 19 严重并发症的高风险:当两种大流行相遇时该怎么办。
J Popul Ther Clin Pharmacol. 2020 Jun 29;27(S Pt 1):e31-e36. doi: 10.15586/jptcp.v27iSP1.708.
4
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率:一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
5
Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.2020 年 3 月 11 日至 5 月 2 日期间 COVID-19 爆发期间超额死亡的初步估计-纽约市。
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):603-605. doi: 10.15585/mmwr.mm6919e5.
6
Obesity: A Risk Factor for COVID-19.肥胖:COVID-19 的风险因素。
Adv Exp Med Biol. 2021;1352:195-210. doi: 10.1007/978-3-030-85109-5_12.
7
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
8
The Centrality of Obesity in the Course of Severe COVID-19.肥胖在重症 COVID-19 病程中的核心地位。
Front Endocrinol (Lausanne). 2021 Mar 11;12:620566. doi: 10.3389/fendo.2021.620566. eCollection 2021.
9
From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.从流感病毒到新型冠状病毒(SARS-CoV-2)——肥胖的贡献。
Front Endocrinol (Lausanne). 2020 Oct 6;11:556962. doi: 10.3389/fendo.2020.556962. eCollection 2020.
10
SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.SARS-CoV-2 扰乱肾素-血管紧张素系统和能量代谢。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E43-E47. doi: 10.1152/ajpendo.00219.2020. Epub 2020 May 29.

引用本文的文献

1
The dynamic linkage between covid-19 and nutrition: a review from a probiotics perspective using machine learning and bibliometric analysis.2019冠状病毒病与营养之间的动态联系:基于机器学习和文献计量分析的益生菌视角综述
Front Nutr. 2025 May 9;12:1575130. doi: 10.3389/fnut.2025.1575130. eCollection 2025.
2
Phase angle (PhA) in overweight and obesity: evidence of applicability from diagnosis to weight changes in obesity treatment.相位角(PhA)在超重和肥胖中的应用:肥胖治疗中从诊断到体重变化的证据。
Rev Endocr Metab Disord. 2023 Jun;24(3):451-464. doi: 10.1007/s11154-022-09774-1. Epub 2022 Dec 9.
3
Does Obesity Paradox Exist in COVID-19 Mortality?

本文引用的文献

1
Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection.新型冠状病毒感染相关凝血功能障碍的风险管理与治疗
Int J Environ Res Public Health. 2021 Jan 31;18(3):1268. doi: 10.3390/ijerph18031268.
2
Autopsy findings in COVID-19-related deaths: a literature review.COVID-19 相关死亡的尸检结果:文献综述。
Forensic Sci Med Pathol. 2021 Jun;17(2):279-296. doi: 10.1007/s12024-020-00310-8. Epub 2020 Oct 7.
3
Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018.成年人肥胖和重度肥胖的患病率:美国,2017-2018 年。
肥胖悖论是否存在于新冠病毒感染死亡率中?
J Obes Metab Syndr. 2022 Sep 30;31(3):199-200. doi: 10.7570/jomes22052.
4
Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors.死于 SARS-CoV-2 感染的患者中的血栓栓塞事件:频率、特征和危险因素。
Thromb Res. 2022 Oct;218:171-176. doi: 10.1016/j.thromres.2022.08.021. Epub 2022 Aug 28.
5
The Impact of the COVID-19 Epidemic on the Mood and Diet of Patients Undergoing Bariatric Surgery.新冠疫情对接受减重手术患者的情绪和饮食的影响。
Nutrients. 2022 Jul 12;14(14):2849. doi: 10.3390/nu14142849.
NCHS Data Brief. 2020 Feb(360):1-8.
4
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素:前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
5
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.肾素-血管紧张素-醛固酮系统阻滞剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1.
6
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.意大利米兰一家学术医院收治的 COVID-19 患者的静脉和动脉血栓栓塞并发症。
Thromb Res. 2020 Jul;191:9-14. doi: 10.1016/j.thromres.2020.04.024. Epub 2020 Apr 23.
7
COVID-19: Immunology and treatment options.新型冠状病毒肺炎:免疫学与治疗选择。
Clin Immunol. 2020 Jun;215:108448. doi: 10.1016/j.clim.2020.108448. Epub 2020 Apr 27.
8
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019.1420 例轻症至中症 2019 年冠状病毒病欧洲患者的临床和流行病学特征。
J Intern Med. 2020 Sep;288(3):335-344. doi: 10.1111/joim.13089. Epub 2020 Jun 17.
9
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.大血管卒中作为年轻人新冠病毒病的首发特征
N Engl J Med. 2020 May 14;382(20):e60. doi: 10.1056/NEJMc2009787. Epub 2020 Apr 28.
10
Obesity and impaired metabolic health in patients with COVID-19.COVID-19 患者的肥胖和代谢健康受损。
Nat Rev Endocrinol. 2020 Jul;16(7):341-342. doi: 10.1038/s41574-020-0364-6.